Lexicon Pharmaceuticals (LXRX)

• Market cap: $523M
• 1 day: -4%
• 5 days: -19.1%
• 1 month: 23.08%
• 3 months: 8.27%
• 6 months: 34.58%
• Year to date: 26.32%
• 1 year: 74.48%
• 5 years: -81.8%
• 10 years: -85.87%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 103